Vir Biotechnology to Present at Cantor Global Virtual Healthcare Conference
SAN FRANCISCO, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today announced that Phil Pang, M.D., Ph.D., chief medical officer of Vir will present at the Cantor Global Virtual Healthcare Conference on Tuesday, September 15th at 8:20 am PT/ 11:20 am ET.
A live webcast of the presentation can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there following the presentation for 30 days.
The Company has used, and intends to continue to use, the Investors page of its website as a means of disclosing mterial non-public information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor the Company’s Investors website, in addition to following the Company’s press releases, Securities and Exchange Commission filings, public conference calls, presentations and webcasts.
About Vir Biotechnology
Contact: Vir Biotechnology, Inc. Investors Neera Ravindran, MD VP, Head of Investor Relations & Strategic Communications email@example.com +1-415-506-5256 Media Julie Normart W2O Group firstname.lastname@example.org +1-559-974-3245
Exhibitor Setup - Hall D
An Edge-to-Edge Smart Building Solution
Utilizing Machine Learning to Predict Public Transportation Times